Shutoff of host gene expression in influenza A virus and herpesviruses: Similar mechanisms and common themes

Viruses

Volumn 8, Issue 4, 2016, Pages

  Rivas, Hembly G ^a   Schmaling, Summer K ^a   Gaglia, Marta M ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Herpes simplex virus; Herpesviruses; Host shutoff; Influenza A virus; Kaposi s sarcoma associated herpesvirus; RNA degradation; Transcription block

Indexed keywords

AU RICH ELEMENT; GENE CONTROL; GENE EXPRESSION; HERPESVIRIDAE; HUMAN; IMMUNE EVASION; INFLUENZA A VIRUS; KAPOSI SARCOMA; NUCLEAR LOCALIZATION SIGNAL; POINT MUTATION; POLYADENYLATION; POSTTRANSCRIPTIONAL GENE SILENCING; REVIEW; RNA DEGRADATION; RNA PROCESSING; RNA SPLICING; RNA STABILITY; RNA TRANSCRIPTION; RNA TRANSLATION; ANIMAL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HERPES VIRUS INFECTION; HOST PATHOGEN INTERACTION; INFLUENZA; METABOLISM; PHYSIOLOGY; PROTEIN DEGRADATION; VIROLOGY; VIRUS REPLICATION;

MESSENGER RNA;

ANIMALS; GENE EXPRESSION REGULATION; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; PROTEOLYSIS; RNA SPLICING; RNA STABILITY; RNA, MESSENGER; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 84964237446     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v8040102     Document Type: Review

References (173)

1. Dauber, B, Saffran, H.A, Smiley, J.R. The herpes simplex virus 1 virion host shutoff protein enhances translation of viral late mRNAs by preventing mRNA overload. J. Virol. 2014, 88, 9624-9632. [CrossRef] [PubMed]
2. Khaperskyy, D.A, Schmaling, S, Larkins-Ford, J, McCormick, C, Gaglia, M.M. Selective degradation of host RNA polymerase II transcripts by influenza A virus PA-X host shutoff protein. PLoS Pathog. 2016, 12, e1005427. [CrossRef] [PubMed]
3. Wu, J, Chen, Z.J. Innate immune sensing and signaling of cytosolic nucleic acids. Annu. Rev. Immunol. 2014, 32, 461-488. [CrossRef] [PubMed]
4. DeWeerd, N.A, Nguyen, T. The interferons and their receptors—Distribution and regulation. Immunol. Cell Biol. 2012, 90, 483-491. [CrossRef] [PubMed]
5. Haller, O, Kochs, G, Weber, F. The interferon response circuit: Induction and suppression by pathogenic viruses. Virology 2006, 344, 119-130. [CrossRef] [PubMed]
6. Tigges, M.A, Leng, S, Johnson, D.C, Burke, R.L. Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled. J. Immunol. 1996, 156, 3901-3910. [PubMed]
7. Rowe, M, Glaunsinger, B, van Leeuwen, D, Zuo, J, Sweetman, D, Ganem, D, Middeldorp, J, Wiertz, E.J.H.J, Ressing, M.E. Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proc. Natl. Acad. Sci. USA 2007, 104, 3366-3371. [CrossRef] [PubMed]
8. Read, G.S, Frenkel, N. Herpes simplex virus mutants defective in the virion-associated shutoff of host polypeptide synthesis and exhibiting abnormal synthesis of alpha (immediate early) viral polypeptides. J. Virol. 1983, 46, 498-512. [PubMed]
9. Kwong, A.D, Frenkel, N. Herpes simplex virus-infected cells contain a function(s) that destabilizes both host and viral mRNAs. Proc. Natl. Acad. Sci. USA 1987, 84, 1926-1930. [CrossRef] [PubMed]
10. Glaunsinger, B, Ganem, D. Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. Mol. Cell 2004, 13, 713-723. [CrossRef]
11. Covarrubias, S, Richner, J.M, Clyde, K, Lee, Y.J, Glaunsinger, B.A. Host shutoff is a conserved phenotype of gammaherpesvirus infection and is orchestrated exclusively from the cytoplasm. J. Virol. 2009, 83, 9554-9566. [CrossRef] [PubMed]
12. Sato, H, Callanan, L.D, Pesnicak, L, Krogmann, T, Cohen, J.I. Varicella-zoster virus (VZV) ORF17 protein induces RNA cleavage and is critical for replication of VZV at 37 degrees C but not 33 degrees C. J. Virol. 2002, 76, 11012-11023. [CrossRef] [PubMed]
13. Lin, H.W, Chang, Y.Y, Wong, M.L, Lin, J.W, Chang, T.J. Functional analysis of virion host shutoff protein of pseudorabies virus. Virology 2004, 324, 412-418. [CrossRef] [PubMed]
14. Elgadi, M.M, Hayes, C.E, Smiley, J.R. The herpes simplex virus vhs protein induces endoribonucleolytic cleavage of target RNAs in cell extracts. J. Virol. 1999, 73, 7153-7164. [PubMed]
15. Everly, D.N, Feng, P, Mian, I.S, Read, G.S. mRNA degradation by the virion host shutoff (vhs) protein of herpes simplex virus: Genetic and biochemical evidence that vhs is a nuclease. J. Virol. 2002, 76, 8560-8571. [CrossRef] [PubMed]
16. Schek, N, Bachenheimer, S.L. Degradation of cellular mRNAs induced by a virion-associated factor during herpes simplex virus infection of Vero cells. J. Virol. 1985, 55, 601-610. [PubMed]
17. Strom, T, Frenkel, N. Effects of herpes simplex virus on mRNA stability. J. Virol. 1987, 61, 2198-2207. [PubMed]
18. Fenwick, M.L, McMenamin, M.M. Early virion-associated suppression of cellular protein synthesis by herpes simplex virus is accompanied by inactivation of mRNA. J. Gen. Virol. 1984, 65, 1225-1228. [CrossRef] [PubMed]
19. Oroskar, A.A, Read, G.S. A mutant of herpes simplex virus type 1 exhibits increased stability of immediate-early (alpha) mRNAs. J. Virol. 1987, 61, 604-606. [PubMed]
20. Oroskar, A.A, Read, G.S. Control of mRNA stability by the virion host shutoff function of herpes simplex virus. J. Virol. 1989, 63, 1897-1906. [PubMed]
21. Korom, M, Wylie, K.M, Morrison, L.A. Selective ablation of virion host shutoff protein RNase activity attenuates herpes simplex virus 2 in mice. J. Virol. 2008, 82, 3642-3653. [CrossRef] [PubMed]
22. Strelow, L.I, Leib, D.A. Role of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis. J. Virol. 1995, 69, 6779-6786. [PubMed]
23. Smith, T.J, Ackland-Berglund, C.E, Leib, D.A. Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice. J. Virol. 2000, 74, 3598-3604. [CrossRef] [PubMed]
24. Smith, T.J, Morrison, L.A, Leib, D.A. Pathogenesis of herpes simplex virus type 2 virion host shutoff (vhs) mutants. J. Virol. 2002, 76, 2054-2061. [CrossRef] [PubMed]
25. Murphy, J.A, Duerst, R.J, Smith, T.J, Morrison, L.A. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J. Virol. 2003, 77, 9337-9345. [CrossRef] [PubMed]
26. Pasieka, T.J, Lu, B, Crosby, S.D, Wylie, K.M, Morrison, L.A, Alexander, D.E, Menachery, V.D, Leib, D.A. Herpes simplex virus virion host shutoff attenuates establishment of the antiviral state. J. Virol. 2008, 82, 5527-5535. [CrossRef] [PubMed]
27. Duerst, R.J, Morrison, L.A. Herpes simplex virus 2 virion host shutoff protein interferes with type I interferon production and responsiveness. Virology 2004, 322, 158-167. [CrossRef] [PubMed]
28. Buisson, M, Géoui, T, Flot, D, Tarbouriech, N, Ressing, M.E, Wiertz, E.J, Burmeister, W.P. A bridge crosses the active-site canyon of the Epstein-Barr virus nuclease with DNase and RNase activities. J. Mol. Biol. 2009, 391, 717-728. [CrossRef] [PubMed]
29. Bagnéris, C, Briggs, L.C, Savva, R, Ebrahimi, B, Barrett, T.E. Crystal structure of a KSHV-SOX-DNA complex: Insights into the molecular mechanisms underlying DNase activity and host shutoff. Nucleic Acids Res. 2011, 39, 5744-5756. [CrossRef] [PubMed]
30. Dahlroth, S.-L, Gurmu, D, Schmitzberger, F, Engman, H, Haas, J, Erlandsen, H, Nordlund, P. Crystal structure of the shutoff and exonuclease protein from the oncogenic Kaposi’s sarcoma-associated herpesvirus. FEBS J. 2009, 276, 6636-6645. [CrossRef] [PubMed]
31. Bujnicki, J.M, Rychlewski, L. The herpesvirus alkaline exonuclease belongs to the restriction endonuclease PD-(D/E)XK superfamily: Insight from molecular modeling and phylogenetic analysis. Virus Genes 2001, 22, 219-230. [CrossRef] [PubMed]
32. Glaunsinger, B, Chavez, L, Ganem, D. The exonuclease and host shutoff functions of the SOX protein of Kaposi’s sarcoma-associated herpesvirus are genetically separable. J. Virol. 2005, 79, 7396-7401. [CrossRef] [PubMed]
33. Covarrubias, S, Gaglia, M.M, Kumar, G.R, Wong, W, Jackson, A.O, Glaunsinger, B.A. Coordinated destruction of cellular messages in translation complexes by the gammaherpesvirus host shutoff factor and the mammalian exonuclease Xrn1. PLoS Pathog. 2011, 7, e1002339. [CrossRef] [PubMed]
34. Richner, J.M, Clyde, K, Pezda, A.C, Cheng, B.Y.H, Wang, T, Kumar, G.R, Covarrubias, S, Coscoy, L, Glaunsinger, B. Global mRNA degradation during lytic gammaherpesvirus infection contributes to establishment of viral latency. PLoS Pathog. 2011, 7, e1002150. [CrossRef] [PubMed]
35. Zuo, J, Thomas, W, van Leeuwen, D, Middeldorp, J.M, Wiertz, E.J.H.J, Ressing, M.E, Rowe, M. The DNase of gammaherpesviruses impairs recognition by virus-specific CD8+ T cells through an additional host shutoff function. J. Virol. 2008, 82, 2385-2393. [CrossRef] [PubMed]
36. Horst, D, Burmeister, W.P, Boer, I.G.J, van Leeuwen, D, Buisson, M, Gorbalenya, A.E, Wiertz, E.J.H.J, Ressing, M.E. The “bridge” in the Epstein-Barr virus alkaline exonuclease protein BGLF5 contributes to shutoff activity during productive infection. J. Virol. 2012, 86, 9175-9187. [CrossRef] [PubMed]
37. Abernathy, E, Clyde, K, Yeasmin, R, Krug, L.T, Burlingame, A, Coscoy, L, Glaunsinger, B. Gammaherpesviral gene expression and virion composition are broadly controlled by accelerated mRNA degradation. PLoS Pathog. 2014, 10, e1003882. [CrossRef] [PubMed]
38. Van Gent, M, Griffin, B.D, Berkhoff, E.G, van Leeuwen, D, Boer, I.G.J, Buisson, M, Hartgers, F.C, Burmeister, W.P, Wiertz, E.J, Ressing, M.E. EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection. J. Immunol. 2011, 186, 1694-1702. [CrossRef] [PubMed]
39. Van Gent, M, Gram, A.M, Boer, I.G.J, Geerdink, R.J, Lindenbergh, M.F.S, Lebbink, R.J, Wiertz, E.J, Ressing, M.E. Silencing the shutoff protein of Epstein-Barr virus in productively infected B cells points to (innate) targets for immune evasion. J. Gen. Virol. 2015, 96, 858-865. [CrossRef] [PubMed]
40. Ressing, M.E, Horst, D, Griffin, B.D, Tellam, J, Zuo, J, Khanna, R, Rowe, M, Wiertz, E.J.H.J. Epstein-Barr virus evasion of CD8+ and CD4+ T cell immunity via concerted actions of multiple gene products. Semin. Cancer Biol. 2008, 18, 397-408. [CrossRef] [PubMed]
41. Gaglia, M.M, Covarrubias, S, Wong, W, Glaunsinger, B.A. A common strategy for host RNA degradation by divergent viruses. J. Virol. 2012, 86, 9527-9530. [CrossRef] [PubMed]
42. Shiflett, L.A, Read, G.S. mRNA decay during herpes simplex virus (HSV) infections: Mutations that affect translation of an mRNA influence the sites at which it is cleaved by the HSV virion host shutoff (vhs) protein. J. Virol. 2013, 87, 94-109. [CrossRef] [PubMed]
43. Taddeo, B, Esclatine, A, Zhang, W, Roizman, B. The stress-inducible immediate-early responsive gene IEX-1 is activated in cells infected with herpes simplex virus 1, but several viral mechanisms, including 31 degradation of its RNA, preclude expression of the gene. J. Virol. 2003, 77, 6178-6187. [CrossRef] [PubMed]
44. Esclatine, A, Taddeo, B, Roizman, B. The UL41 protein of herpes simplex virus mediates selective stabilization or degradation of cellular mRNAs. Proc. Natl. Acad. Sci. USA 2004, 101, 18165-18170. [CrossRef] [PubMed]
45. Shu, M, Taddeo, B, Roizman, B. Tristetraprolin recruits the herpes simplex virion host shutoff RNase to AU-rich elements in stress response mRNAs to enable their cleavage. J. Virol. 2015, 89, 5643-5650. [CrossRef] [PubMed]
46. Feng, P, Everly, D.N, Read, G.S. mRNA decay during herpesvirus infections: Interaction between a putative viral nuclease and a cellular translation factor. J. Virol. 2001, 75, 10272-10280. [CrossRef] [PubMed]
47. Feng, P, Everly, D.N, Read, G.S. mRNA decay during herpes simplex virus (HSV) infections: Protein-protein interactions involving the HSV virion host shutoff protein and translation factors eIF4H and eIF4A. J. Virol. 2005, 79, 9651-9664. [CrossRef] [PubMed]
48. Page, H.G, Read, G.S. The virion host shutoff endonuclease (UL41) of herpes simplex virus interacts with the cellular cap-binding complex eIF4F. J. Virol. 2010, 84, 6886-6890. [CrossRef] [PubMed]
49. Lu, P, Saffran, H.A, Smiley, J.R. The vhs1 mutant form of herpes simplex virus virion host shutoff protein retains significant internal ribosome entry site-directed RNA cleavage activity. J. Virol. 2001, 75, 1072-1076. [CrossRef] [PubMed]
50. Sarma, N, Agarwal, D, Shiflett, L.A, Read, G.S. Small interfering RNAs that deplete the cellular translation factor eIF4H impede mRNA degradation by the virion host shutoff protein of herpes simplex virus. J. Virol. 2008, 82, 6600-6609. [CrossRef] [PubMed]
51. Von Roretz, C, Marco, S.D, Mazroui, R, Gallouzi, I.E. Turnover of AU-rich-containing mRNAs during stress: A matter of survival. Wiley Interdiscip. Rev. RNA 2011, 2, 336-347. [CrossRef] [PubMed]
52. Schott, J, Stoecklin, G. Networks controllingmRNAdecay in the immune system. Wiley Interdiscip. Rev. RNA 2010, 1, 432-456. [CrossRef] [PubMed]
53. Shu, M, Taddeo, B, Roizman, B. The nuclear-cytoplasmic shuttling of virion host shutoff RNase is enabled by pUL47 and an Embedded nuclear export signal and defines the sites of degradation of AU-rich and stable cellular mRNAs. J. Virol. 2013, 87, 13569-13578. [CrossRef] [PubMed]
54. Gaglia, M.M, Rycroft, C.H, Glaunsinger, B.A. Transcriptome-wide cleavage site mapping on cellular mRNAs reveals features underlying sequence-specific cleavage by the viral ribonuclease SOX. PLoS Pathog. 2015, 11, e1005305. [CrossRef] [PubMed]
55. Clyde, K, Glaunsinger, B.A. Deep sequencing reveals direct targets of gammaherpesvirus-induced mRNA decay and suggests that multiple mechanisms govern cellular transcript escape. PLoS ONE 2011, 6, e19655. [CrossRef] [PubMed]
56. Smibert, C.A, Popova, B, Xiao, P, Capone, J.P, Smiley, J.R. Herpes simplex virus VP16 forms a complex with the virion host shutoff protein vhs. J. Virol. 1994, 68, 2339-2346. [PubMed]
57. Lam, Q, Smibert, C.A, Koop, K.E, Lavery, C, Capone, J.P, Weinheimer, S.P, Smiley, J.R. Herpes simplex virus VP16 rescues viral mRNA from destruction by the virion host shutoff function. EMBO J. 1996, 15, 2575-2581. [PubMed]
58. Knez, J, Bilan, P.T, Capone, J.P. A single amino acid substitution in herpes simplex virus type 1 VP16 inhibits binding to the virion host shutoff protein and is incompatible with virus growth. J. Virol. 2003, 77, 2892-2902. [CrossRef] [PubMed]
59. Taddeo, B, Sciortino, M.T, Zhang, W, Roizman, B. Interaction of herpes simplex virus RNase with VP16 and VP22 is required for the accumulation of the protein but not for accumulation of mRNA. Proc. Natl. Acad. Sci. USA 2007, 104, 12163-12168. [CrossRef] [PubMed]
60. Sciortino, M.T, Taddeo, B, Giuffrè-Cuculletto, M, Medici, M.A, Mastino, A, Roizman, B. Replication-competent herpes simplex virus 1 isolates selected from cells transfected with a bacterial artificial chromosome DNA lacking only the UL49 gene vary with respect to the defect in the UL41 gene encoding host shutoff RNase. J. Virol. 2007, 81, 10924-10932. [CrossRef] [PubMed]
61. Taddeo, B, Zhang, W, Roizman, B. The herpes simplex virus host shutoff RNase degrades cellular and viral mRNAs made before infection but not viral mRNA made after infection. J. Virol. 2013, 87, 4516-4522. [CrossRef] [PubMed]
62. Shu, M, Taddeo, B, Zhang, W, Roizman, B. Selective degradation of mRNAs by the HSV host shutoff RNase is regulated by the UL47 tegument protein. Proc. Natl. Acad. Sci. USA 2013, 110, E1669-E1675. [CrossRef] [PubMed]
63. Feederle, R, Mehl-Lautscham, A.M, Bannert, H, Delecluse, H.J. The Epstein-Barr virus protein kinase BGLF4 and the exonuclease BGLF5 have opposite effects on the regulation of viral protein production. J. Virol. 2009, 83, 10877-10891. [CrossRef] [PubMed]
64. Feederle, R, Bannert, H, Lips, H, Müller-Lantzsch, N, Delecluse, H.J. The Epstein-Barr virus alkaline exonuclease BGLF5 serves pleiotropic functions in virus replication. J. Virol. 2009, 83, 4952-4962. [CrossRef] [PubMed]
65. Ganem, D. KSHV and the pathogenesis of Kaposi sarcoma: Listening to human biology and medicine. J. Clin. Investig. 2010, 120, 939-949. [CrossRef] [PubMed]
66. Gantt, S, Casper, C. Human herpesvirus 8-associated neoplasms: The roles of viral replication and antiviral treatment. Curr. Opin. Infect. Dis. 2011, 24, 295-301. [CrossRef] [PubMed]
67. Glaunsinger, B, Ganem, D. Highly selective escape from KSHV-mediated host mRNA shutoff and its implications for viral pathogenesis. J. Exp. Med. 2004, 200, 391-398. [CrossRef] [PubMed]
68. Asou, H, Said, J.W, Yang, R, Munker, R, Park, D.J, Kamada, N, Koeffler, H.P. Mechanisms of growth control of Kaposi’s sarcoma-associated herpes virus-associated primary effusion lymphoma cells. Blood 1998, 91, 2475-2481. [PubMed]
69. Leger-Ravet, M.B, Peuchmaur, M, Devergne, O, Audouin, J, Raphael, M, Damme, J.V, Galanaud, P, Diebold, J, Emilie, D. Interleukin-6 gene expression in Castleman’s disease. Blood 1991, 78, 2923-2930. [PubMed]
70. Hutin, S, Lee, Y, Glaunsinger, B.A. An RNA element in human interleukin 6 confers escape from degradation by the gammaherpesvirus SOX protein. J. Virol. 2013, 87, 4672-4682. [CrossRef] [PubMed]
71. Muller, M, Hutin, S, Marigold, O, Li, K.H, Burlingame, A, Glaunsinger, B.A. A ribonucleoprotein complex protects the interleukin-6 mRNA from degradation by distinct herpesviral endonucleases. PLoS Pathog. 2015, 11, e1004899. [CrossRef] [PubMed]
72. Saffran, H.A, Pare, J.M, Corcoran, J.A, Weller, S.K, Smiley, J.R. Herpes simplex virus eliminates host mitochondrial DNA. EMBO Rep. 2007, 8, 188-193. [CrossRef] [PubMed]
73. Duguay, B.A, Saffran, H.A, Ponomarev, A, Duley, S.A, Eaton, H.E, Smiley, J.R. Elimination of mitochondrial DNA is not required for herpes simplex virus 1 replication. J. Virol. 2014, 88, 2967-2976. [CrossRef] [PubMed]
74. Martinez, R, Shao, L, Bronstein, J.C, Weber, P.C, Weller, S.K. The product of a 1.9-kb mRNA which overlaps the HSV-1 alkaline nuclease gene (UL12) cannot relieve the growth defects of a null mutant. Virology 1996, 215, 152-164. [CrossRef] [PubMed]
75. Reuven, N.B, Antoku, S, Weller, S.K. The UL12.5 gene product of herpes simplex virus type 1 exhibits nuclease and strand exchange activities but does not localize to the nucleus. J. Virol. 2004, 78, 4599-4608. [CrossRef] [PubMed]
76. Corcoran, J.A, Saffran, H.A, Duguay, B.A, Smiley, J.R. Herpes simplex virus UL12.5 targets mitochondria through a mitochondrial localization sequence proximal to the N terminus. J. Virol. 2009, 83, 2601-2610. [CrossRef] [PubMed]
77. Duguay, B.A, Smiley, J.R. Mitochondrial nucleases ENDOG and EXOG participate in mitochondrial DNA depletion initiated by herpes simplex virus 1 UL12.5. J. Virol. 2013, 87, 11787-11797. [CrossRef] [PubMed]
78. Martinez, R, Goldstein, J.N, Weller, S.K. The product of the UL12.5 gene of herpes simplex virus type 1 is not essential for lytic viral growth and is not specifically associated with capsids. Virology 2002, 298, 248-257. [CrossRef] [PubMed]
79. West, A.P, Khoury-Hanold, W, Staron, M, Tal, M.C, Pineda, C.M, Lang, S.M, Bestwick, M, Duguay, B.A, Raimundo, N, MacDuff, D.A, et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature 2015, 520, 553-557. [CrossRef] [PubMed]
80. Lee, Y.J, Glaunsinger, B.A. Aberrant herpesvirus-induced polyadenylation correlates with cellular messenger RNA destruction. PLoS Biol. 2009, 7, e1000107. [CrossRef] [PubMed]
81. Kumar, G.R, Glaunsinger, B.A. Nuclear import of cytoplasmic poly(A) binding protein restricts gene expression via hyperadenylation and nuclear retention of mRNA. Mol. Cell. Biol. 2010, 30, 4996-5008. [CrossRef] [PubMed]
82. Afonina, E, Stauber, R, Pavlakis, G.N. The human poly(A)-binding protein 1 shuttles between the nucleus and the cytoplasm. J. Biol. Chem. 1998, 273, 13015-13021. [CrossRef] [PubMed]
83. Ma, S, Bhattacharjee, R.B, Bag, J. Expression of poly(A)-binding protein is upregulated during recovery from heat shock in HeLa cells. FEBS J. 2009, 276, 552-570. [CrossRef] [PubMed]
84. Salaun, C, MacDonald, A.I, Larralde, O, Howard, L, Lochtie, K, Burgess, H.M, Brook, M, Malik, P, Gray, N.K, Graham, S.V. Poly(A)-binding protein 1 partially relocalizes to the nucleus during herpes simplex virus type 1 infection in an ICP27-independent manner and does not inhibit virus replication. J. Virol. 2010, 84, 8539-8548. [CrossRef] [PubMed]
85. Kumar, G.R, Shum, L, Glaunsinger, B.A. Importin-mediated nuclear import of cytoplasmic poly(A) binding protein occurs as a direct consequence of cytoplasmic mRNA depletion. Mol. Cell. Biol. 2011, 31, 3113-3125. [CrossRef] [PubMed]
86. Lange, A, Mills, R.E, Lange, C.J, Stewart, M, Devine, S.E, Corbett, A.H. Classical nuclear localization signals: Definition, function, and interaction with importin. J. Biol. Chem. 2007, 282, 5101-5105. [CrossRef] [PubMed]
87. Khaperskyy, D.A, Emara, M.M, Johnston, B.P, Anderson, P, Hatchette, T.F, McCormick, C. Influenza A virus host shutoff disables antiviral stress-induced translation arrest. PLoS Pathog. 2014, 10, e1004217. [CrossRef] [PubMed]
88. Abernathy, E, Gilbertson, S, Alla, R, Glaunsinger, B. Viral nucleases induce an mRNA degradation-transcription feedback loop in mammalian cells. Cell Host Microbe 2015, 18, 243-253. [CrossRef] [PubMed]
89. Dauber, B, Pelletier, J, Smiley, J.R. The herpes simplex virus 1 vhs protein enhances translation of viral true late mRNAs and virus production in a cell type-dependent manner. J. Virol. 2011, 85, 5363-5373. [CrossRef] [PubMed]
90. Finnen, R.L, Hay, T.J.M, Dauber, B, Smiley, J.R, Banfield, B.W. The herpes simplex virus 2 virion-associated ribonuclease vhs interferes with stress granule formation. J. Virol. 2014, 88, 12727-12739. [CrossRef] [PubMed]
91. Anderson, P, Kedersha, N. Stress granules: The Tao of RNA triage. Trends Biochem. Sci. 2008, 33, 141-150. [CrossRef] [PubMed]
92. Beckham, C.J, Parker, R. P bodies, stress granules, and viral life cycles. Cell Host Microbe 2008, 3, 206-212. [CrossRef] [PubMed]
93. Finnen, R.L, Pangka, K.R, Banfield, B.W. Herpes simplex virus 2 infection impacts stress granule accumulation. J. Virol. 2012, 86, 8119-8130. [CrossRef] [PubMed]
94. Li, W, Li, Y, Kedersha, N, Anderson, P, Emara, M, Swiderek, K.M, Moreno, G.T, Brinton, M.A. Cell proteins TIA-1 and TIAR interact with the 31 stem-loop of the West Nile virus complementary minus-strand RNA and facilitate virus replication. J. Virol. 2002, 76, 11989-12000. [CrossRef] [PubMed]
95. Chandriani, S, Ganem, D. Host transcript accumulation during lytic KSHV infection reveals several classes of host responses. PLoS ONE 2007, 2. [CrossRef] [PubMed]
96. Chang, P.C, Fitzgerald, L.D, Hsia, D.A, Izumiya, Y, Wu, C.Y, Hsieh, W.P, Lin, S.F, Campbell, M, Lam, K.S, Luciw, P.A, et al. Histone demethylase JMJD2A regulates Kaposi’s sarcoma-associated herpesvirus replication and is targeted by a viral transcriptional factor. J. Virol. 2011, 85, 3283-3293. [CrossRef] [PubMed]
97. Sandri-Goldin, R.M. The many roles of the regulatory protein ICP27 during herpes simplex virus infection. Front. Biosci. J. Virtual Libr. 2008, 13, 5241-5256. [CrossRef]
98. Sandri-Goldin, R.M. The many roles of the highly interactive HSV protein ICP27, a key regulator of infection. Future Microbiol. 2011, 6, 1261-1277. [CrossRef] [PubMed]
99. Hardwicke, M.A, Sandri-Goldin, R.M. The herpes simplex virus regulatory protein ICP27 contributes to the decrease in cellular mRNA levels during infection. J. Virol. 1994, 68, 4797-4810. [PubMed]
100. Hardy, W.R, Sandri-Goldin, R.M. Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect. J. Virol. 1994, 68, 7790-7799. [PubMed]
101. Luo, M, Reed, R. Splicing is required for rapid and efficient mRNA export in metazoans. Proc. Natl. Acad. Sci. USA 1999, 96, 14937-14942. [CrossRef] [PubMed]
102. Nojima, T, Oshiro-Ideue, T, Nakanoya, H, Kawamura, H, Morimoto, T, Kawaguchi, Y, Kataoka, N, Hagiwara, M. Herpesvirus protein ICP27 switches PML isoform by altering mRNA splicing. Nucleic Acids Res. 2009, 37, 6515-6527. [CrossRef] [PubMed]
103. Park, D, Lalli, J, Sedlackova-Slavikova, L, Rice, S.A. Functional comparison of herpes simplex virus 1 (HSV-1) and HSV-2 ICP27 homologs reveals a role for ICP27 in virion release. J. Virol. 2015, 89, 2892-2905. [CrossRef] [PubMed]
104. Lindberg, A, Kreivi, J.-P. Splicing inhibition at the level of spliceosome assembly in the presence of herpes simplex virus protein ICP27. Virology 2002, 294, 189-198. [CrossRef] [PubMed]
105. Bryant, H.E, Wadd, S.E, Lamond, A.I, Silverstein, S.J, Clements, J.B. Herpes simplex virus IE63 (ICP27) protein interacts with spliceosome-associated protein 145 and inhibits splicing prior to the first catalytic step. J. Virol. 2001, 75, 4376-4385. [CrossRef] [PubMed]
106. Sciabica, K.S, Dai, Q.J, Sandri-Goldin, R.M. ICP27 interacts with SRPK1 to mediate HSV splicing inhibition by altering SR protein phosphorylation. EMBO J. 2003, 22, 1608-1619. [CrossRef] [PubMed]
107. Champion-Arnaud, P, Reed, R. The prespliceosome components SAP 49 and SAP 145 interact in a complex implicated in tethering U2 snRNP to the branch site. Genes Dev. 1994, 8, 1974-1983. [CrossRef] [PubMed]
108. Graveley, B.R. Sorting out the complexity of SR protein functions. RNA 2000, 6, 1197-1211. [CrossRef] [PubMed]
109. Roscigno, R.F, Garcia-Blanco, M.A. SR proteins escort the U4/U6.U5 tri-snRNP to the spliceosome. RNA 1995, 1, 692-706. [PubMed]
110. Prasad, J, Colwill, K, Pawson, T, Manley, J.L. The protein kinase Clk/Sty directly modulates SR protein activity: Both hyper- and hypophosphorylation inhibit splicing. Mol. Cell. Biol. 1999, 19, 6991-7000. [CrossRef] [PubMed]
111. Rutkowski, A.J, Erhard, F, L’Hernault, A, Bonfert, T, Schilhabel, M, Crump, C, Rosenstiel, P, Efstathiou, S, Zimmer, R, Friedel, C.C, et al. Widespread disruption of host transcription termination in HSV-1 infection. Nat. Commun. 2015, 6. [CrossRef] [PubMed]
112. Preston, C.M, Newton, A.A. The effects of herpes simplex virus type 1 on cellular DNA-dependent RNA polymerase activities. J. Gen. Virol. 1976, 33, 471-482. [CrossRef] [PubMed]
113. Wagner, E.K, Roizman, B. Ribonucleic acid synthesis in cells infected with herpes simplex virus I. Patterns of ribonucleic acid synthesis in productively infected cells. J. Virol. 1969, 4, 36-46. [PubMed]
114. Abrisch, R.G, Eidem, T.M, Yakovchuk, P, Kugel, J.F, Goodrich, J.A. Infection by herpes simplex virus 1 causes near-complete loss of RNA polymerase II occupancy on the host cell genome. J. Virol. 2016, 90, 2503-2513. [CrossRef] [PubMed]
115. Heidemann, M, Hintermair, C, Voß, K, Eick, D. Dynamic phosphorylation patterns of RNA polymerase II CTD during transcription. Biochim. Biophys. Acta 2013, 1829, 55-62. [CrossRef] [PubMed]
116. Rice, S.A, Long, M.C, Lam, V, Spencer, C.A. RNA polymerase II is aberrantly phosphorylated and localized to viral replication compartments following herpes simplex virus infection. J. Virol. 1994, 68, 988-1001. [PubMed]
117. Fraser, K.A, Rice, S.A. Herpes simplex virus type 1 infection leads to loss of serine-2 phosphorylation on the carboxyl-terminal domain of RNA polymerase II. J. Virol. 2005, 79, 11323-11334. [CrossRef] [PubMed]
118. Fraser, K.A, Rice, S.A. Herpes simplex virus immediate-early protein ICP22 triggers loss of serine 2-phosphorylated RNA polymerase II. J. Virol. 2007, 81, 5091-5101. [CrossRef] [PubMed]
119. Dai-Ju, J.Q, Li, L, Johnson, L.A, Sandri-Goldin, R.M. ICP27 interacts with the C-terminal domain of RNA polymerase II and facilitates its recruitment to herpes simplex virus 1 transcription sites, where it undergoes proteasomal degradation during infection. J. Virol. 2006, 80, 3567-3581. [CrossRef] [PubMed]
120. Durand, L.O, Advani, S.J, Poon, A.P.W, Roizman, B. The carboxyl-terminal domain of RNA polymerase II is phosphorylated by a complex containing CDK9 and infected-cell protein 22 of herpes simplex virus 1. J. Virol. 2005, 79, 6757-6762. [CrossRef] [PubMed]
121. Zaborowska, J, Baumli, S, Laitem, C, O’Reilly, D, Thomas, P.H, O’Hare, P, Murphy, S. Herpes simplex virus 1 (HSV-1) ICP22 protein directly interacts with cyclin-dependent kinase (CDK)9 to inhibit RNA polymerase II transcription elongation. PLOS ONE 2014, 9, e107654. [CrossRef] [PubMed]
122. Hargreaves, D.C, Horng, T, Medzhitov, R. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 2009, 138, 129-145. [CrossRef] [PubMed]
123. Gu, B, Eick, D, Bensaude, O. CTD serine-2 plays a critical role in splicing and termination factor recruitment to RNA polymerase II in vivo. Nucleic Acids Res. 2013, 41, 1591-1603. [CrossRef] [PubMed]
124. Vasin, A.V, Temkina, O.A, Egorov, V.V, Klotchenko, S.A, Plotnikova, M.A, Kiselev, O.I. Molecular mechanisms enhancing the proteome of influenza A viruses: An overview of recently discovered proteins. Virus Res. 2014, 185, 53-63. [CrossRef] [PubMed]
125. Inglis, S.C. Inhibition of host protein synthesis and degradation of cellular mRNAs during infection by influenza and herpes simplex virus. Mol. Cell. Biol. 1982, 2, 1644-1648. [CrossRef] [PubMed]
126. Krug, R.M. Functions of the influenza A virus NS1 protein in antiviral defense. Curr. Opin. Virol. 2015, 12, 1-6. [CrossRef] [PubMed]
127. Hale, B.G, Randall, R.E, Ortín, J, Jackson, D. The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 2008, 89, 2359-2376. [CrossRef] [PubMed]
128. Egorov, A, Brandt, S, Sereinig, S, Romanova, J, Ferko, B, Katinger, D, Grassauer, A, Alexandrova, G, Katinger, H, Muster, T. Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells. J. Virol. 1998, 72, 6437-6441. [PubMed]
129. García-Sastre, A, Egorov, A, Matassov, D, Brandt, S, Levy, D.E, Durbin, J.E, Palese, P, Muster, T. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 1998, 252, 324-330. [CrossRef] [PubMed]
130. Qiu, Y, Krug, R.M. The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J. Virol. 1994, 68, 2425-2432. [PubMed]
131. Fortes, P, Beloso, A, Ortín, J. Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J. 1994, 13, 704-712. [PubMed]
132. Nemeroff, M.E, Barabino, S.M, Li, Y, Keller, W, Krug, R.M. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 31 end formation of cellular pre-mRNAs. Mol. Cell 1998, 1, 991-1000. [CrossRef]
133. Chen, Z, Li, Y, Krug, R.M. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 31-end processing machinery. EMBO J. 1999, 18, 2273-2283. [CrossRef] [PubMed]
134. Chan, S, Choi, E.A, Shi, Y. Pre-mRNA 31-end processing complex assembly and function. Wiley Interdiscip. Rev. RNA 2011, 2, 321-335. [CrossRef] [PubMed]
135. Kuss, S.K, Mata, M.A, Zhang, L, Fontoura, B.M.A. Nuclear imprisonment: Viral strategies to arrest host mRNA nuclear export. Viruses 2013, 5, 1824-1849. [CrossRef] [PubMed]
136. Satterly, N, Tsai, P.L, van Deursen, J, Nussenzveig, D.R, Wang, Y, Faria, P.A, Levay, A, Levy, D.E, Fontoura, B.M.A. Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc. Natl. Acad. Sci. USA 2007, 104, 1853-1858. [CrossRef] [PubMed]
137. Stutz, F, Izaurralde, E. The interplay of nuclear mRNP assembly, mRNA surveillance and export. Trends Cell Biol. 2003, 13, 319-327. [CrossRef]
138. Zhang, L, Das, P, Schmolke, M, Manicassamy, B, Wang, Y, Deng, X, Cai, L, Tu, B.P, Forst, C.V, Roth, M.G, et al. Inhibition of pyrimidine synthesis reverses viral virulence factor-mediated block of mRNA nuclear export. J. Cell Biol. 2012, 196, 315-326. [CrossRef] [PubMed]
139. Poon, L.L, Pritlove, D.C, Fodor, E, Brownlee, G.G. Direct evidence that the poly(A) tail of influenza A virus mRNA is synthesized by reiterative copying of a U track in the virion RNA template. J. Virol. 1999, 73, 3473-3476. [PubMed]
140. York, A, Fodor, E. Biogenesis, assembly, and export of viral messenger ribonucleoproteins in the influenza A virus infected cell. RNA Biol. 2013, 10, 1274-1282. [CrossRef] [PubMed]
141. Kainov, D.E, Müller, K.H, Theisen, L.L, Anastasina, M, Kaloinen, M, Muller, C.P. Differential effects of NS1 proteins of human pandemic H1N1/2009, avian highly pathogenic H5N1, and low pathogenic H5N2 influenza A viruses on cellular pre-mRNA polyadenylation and mRNA translation. J. Biol. Chem. 2011, 286, 7239-7247. [CrossRef] [PubMed]
142. Twu, K.Y, Kuo, R.L, Marklund, J, Krug, R.M. The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells. J. Virol. 2007, 81, 8112-8121. [CrossRef] [PubMed]
143. Hale, B.G, Steel, J, Medina, R.A, Manicassamy, B, Ye, J, Hickman, D, Hai, R, Schmolke, M, Lowen, A.C, Perez, D.R, et al. Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J. Virol. 2010, 84, 6909-6922. [CrossRef] [PubMed]
144. Kochs, G, García-Sastre, A, Martínez-Sobrido, L. Multiple anti-interferon actions of the influenza A virus NS1 protein. J. Virol. 2007, 81, 7011-7021. [CrossRef] [PubMed]
145. Ayllon, J, Domingues, P, Rajsbaum, R, Miorin, L, Schmolke, M, Hale, B.G, García-Sastre, A. A single amino acid substitution in the novel H7N9 influenza A virus NS1 protein increases CPSF30 binding and virulence. J. Virol. 2014, 88, 12146-12151. [CrossRef] [PubMed]
146. Das, K, Ma, L.C, Xiao, R, Radvansky, B, Aramini, J, Zhao, L, Marklund, J, Kuo, R.L, Twu, K.Y, Arnold, E, et al. Structural basis for suppression of a host antiviral response by influenza A virus. Proc. Natl. Acad. Sci. USA 2008, 105, 13093-13098. [CrossRef] [PubMed]
147. Spesock, A, Malur, M, Hossain, M.J, Chen, L.M, Njaa, B.L, Davis, C.T, Lipatov, A.S, York, I.A, Krug, R.M, Donis, R.O. The virulence of 1997 H5N1 influenza viruses in the mouse model is increased by correcting a defect in their NS1 proteins. J. Virol. 2011, 85, 7048-7058. [CrossRef] [PubMed]
148. Chan, A.Y, Vreede, F.T, Smith, M, Engelhardt, O.G, Fodor, E. Influenza virus inhibits RNA polymerase II elongation. Virology 2006, 351, 210-217. [CrossRef] [PubMed]
149. Engelhardt, O.G, Smith, M, Fodor, E. Association of the influenza A virus RNA-dependent RNA polymerase with cellular RNA polymerase II. J. Virol. 2005, 79, 5812-5818. [CrossRef] [PubMed]
150. Spooner, L.L.R, Barry, R.D. Participation of DNA-dependent RNA polymerase II in replication of influenza viruses. Nature 1977, 268, 650-652. [CrossRef] [PubMed]
151. Plotch, S.J, Bouloy, M, Ulmanen, I, Krug, R.M. A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell 1981, 23, 847-858. [CrossRef]
152. Rodriguez, A, Pérez-González, A, Nieto, A. Influenza virus infection causes specific degradation of the largest subunit of cellular RNA polymerase II. J. Virol. 2007, 81, 5315-5324. [CrossRef] [PubMed]
153. Vreede, F.T, Chan, A.Y, Sharps, J, Fodor, E. Mechanisms and functional implications of the degradation of host RNA polymerase II in influenza virus infected cells. Virology 2010, 396, 125-134. [CrossRef] [PubMed]
154. Vreede, F.T, Fodor, E. The role of the influenza virus RNA polymerase in host shut-off. Virulence 2010, 1, 436-439. [CrossRef] [PubMed]
155. Llompart, C.M, Nieto, A, Rodriguez-Frandsen, A. Specific residues of PB2 and PA influenza virus polymerase subunits confer the ability for RNA polymerase II degradation and virus pathogenicity in mice. J. Virol. 2014, 88, 3455-3463. [CrossRef] [PubMed]
156. Beloso, A, Martínez, C, Valcárcel, J, Santarén, J.F, Ortín, J. Degradation of cellular mRNA during influenza virus infection: Its possible role in protein synthesis shutoff. J. Gen. Virol. 1992, 73, 575-581. [CrossRef] [PubMed]
157. Jagger, B.W, Wise, H.M, Kash, J.C, Walters, K.-A, Wills, N.M, Xiao, Y.-L, Dunfee, R.L, Schwartzman, L.M, Ozinsky, A, Bell, G.L, et al. An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 2012, 337, 199-204. [CrossRef] [PubMed]
158. Firth, A.E, Jagger, B.W, Wise, H.M, Nelson, C.C, Parsawar, K, Wills, N.M, Napthine, S, Taubenberger, J.K, Digard, P, Atkins, J.F. Ribosomal frameshifting used in influenza A virus expression occurs within the sequence UCC_UUU_CGU and is in the +1 direction. Open Biol. 2012, 2. [CrossRef] [PubMed]
159. Dias, A, Bouvier, D, Crépin, T, McCarthy, A.A, Hart, D.J, Baudin, F, Cusack, S, Ruigrok, R.W.H. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 2009, 458, 914-918. [CrossRef] [PubMed]
160. Yuan, P, Bartlam, M, Lou, Z, Chen, S, Zhou, J, He, X, Lv, Z, Ge, R, Li, X, Deng, T, et al. Crystal structure of an avian influenza polymerase PAN reveals an endonuclease active site. Nature 2009, 458, 909-913. [CrossRef] [PubMed]
161. Oishi, K, Yamayoshi, S, Kawaoka, Y. Mapping of a region of the PA-X protein of influenza A virus that is important for its shutoff activity. J. Virol. 2015, 89, 8661-8665. [CrossRef] [PubMed]
162. Desmet, E.A, Bussey, K.A, Stone, R, Takimoto, T. Identification of the N-terminal domain of the influenza virus PA responsible for the suppression of host protein synthesis. J. Virol. 2013, 87, 3108-3118. [CrossRef] [PubMed]
163. Gao, H, Sun, H, Hu, J, Qi, L, Wang, J, Xiong, X, Wang, Y, He, Q, Lin, Y, Kong, W, Seng, L.G, et al. The 20 amino acids at the C-terminus of PA-X are associated with increased influenza A virus replication and pathogenicity. J. Gen. Virol. 2015, 96, 2036-2049. [CrossRef] [PubMed]
164. Hayashi, T, MacDonald, L.A, Takimoto, T. Influenza A virus protein PA-X contributes to viral growth and suppression of the host antiviral and immune responses. J. Virol. 2015, 89, 6442-6452. [CrossRef] [PubMed]
165. Gao, H, Sun, Y, Hu, J, Qi, L, Wang, J, Xiong, X, Wang, Y, He, Q, Lin, Y, Kong, W, et al. The contribution of PA-X to the virulence of pandemic 2009 H1N1 and highly pathogenic H5N1 avian influenza viruses. Sci. Rep. 2015, 5. [CrossRef] [PubMed]
166. Hu, J, Mo, Y, Wang, X, Gu, M, Hu, Z, Zhong, L, Wu, Q, Hao, X, Hu, S, Liu, W, et al. PA-X decreases the pathogenicity of highly pathogenic H5N1 influenza A virus in avian species by inhibiting virus replication and host response. J. Virol. 2015, 89, 4126-4142. [CrossRef] [PubMed]
167. Gao, H, Xu, G, Sun, Y, Qi, L, Wang, J, Kong, W, Sun, H, Pu, J, Chang, K.C, Liu, J. PA-X is a virulence factor in avian H9N2 influenza virus. J. Gen. Virol. 2015, 96, 2587-2594. [CrossRef] [PubMed]
168. Xu, G, Zhang, X, Sun, Y, Liu, Q, Sun, H, Xiong, X, Jiang, M, He, Q, Wang, Y, Pu, J, Guo, X, Yang, H, Liu, J. Truncation of C-terminal 20 amino acids in PA-X contributes to adaptation of swine influenza virus in pigs. Sci. Rep. 2016, 6. [CrossRef] [PubMed]
169. Bavagnoli, L, Cucuzza, S, Campanini, G, Rovida, F, Paolucci, S, Baldanti, F, Maga, G. The novel influenza A virus protein PA-X and its naturally deleted variant show different enzymatic properties in comparison to the viral endonuclease PA. Nucleic Acids Res. 2015, 43, 9405-9417. [CrossRef] [PubMed]
170. De la Luna, S, Fortes, P, Beloso, A, Ortín, J. Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J. Virol. 1995, 69, 2427-2433. [PubMed]
171. Khaperskyy, D.A, Hatchette, T.F, McCormick, C. Influenza A virus inhibits cytoplasmic stress granule formation. FASEB J. 2012, 26, 1629-1639. [CrossRef] [PubMed]
172. Shi, M, Jagger, B.W, Wise, H.M, Digard, P, Holmes, E.C, Taubenberger, J.K. Evolutionary conservation of the PA-X open reading frame in segment 3 of influenza A Virus. J. Virol. 2012, 86, 12411-12413. [CrossRef] [PubMed]
173. Khaperskyy, D.A, McCormick, C. Timing is everything: Coordinated control of host shutoff by influenza A virus NS1 and PA-X proteins. J. Virol. 2015, 89, 6528-6531. [CrossRef] [PubMed]